0001062993-23-022120.txt : 20231207 0001062993-23-022120.hdr.sgml : 20231207 20231207195735 ACCESSION NUMBER: 0001062993-23-022120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231206 FILED AS OF DATE: 20231207 DATE AS OF CHANGE: 20231207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Edward F CENTRAL INDEX KEY: 0001368350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 231473728 MAIL ADDRESS: STREET 1: C/O POLYMEDIX, INC. STREET 2: 3701 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 780-0819 MAIL ADDRESS: STREET 1: 3940 TRUST WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2023-12-06 0001808898 Benitec Biopharma Inc. BNTC 0001368350 Smith Edward F C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 0 0 0 0 Options (right to buy) 3.1301 2023-12-06 4 A 0 35000 0 A 2033-12-06 Common Stock 35000 35000 D The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant. /s/ Edward Smith 2023-12-07